Cargando…
Perspectives of Molecular Therapy-Targeted Mitochondrial Fission in Hepatocellular Carcinoma
Current advances of molecular-targeting therapies for hepatocellular carcinoma (HCC) have improved the overall survival significantly, whereas the results still remain unsatisfied. Recently, much attention has been focused on organelles, such as the mitochondria, to reveal novel strategies to contro...
Autores principales: | Zhang, Hanwen, Ye, Yanshuo, Li, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785342/ https://www.ncbi.nlm.nih.gov/pubmed/33457401 http://dx.doi.org/10.1155/2020/1039312 |
Ejemplares similares
-
Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma
por: Liu, Ziyu, et al.
Publicado: (2019) -
Fis1 phosphorylation by Met promotes mitochondrial fission and hepatocellular carcinoma metastasis
por: Yu, Yan, et al.
Publicado: (2021) -
Targeting mitochondrial fusion and fission proteins for cardioprotection
por: Hernandez‐Resendiz, Sauri, et al.
Publicado: (2020) -
Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies
por: Alqahtani, Ali, et al.
Publicado: (2019) -
A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma
por: Faltermeier, Claire, et al.
Publicado: (2015)